A citation-based method for searching scientific literature

Stacey A Bélanger, Joannie Caron. Paediatr Child Health 2018
Times Cited: 15







List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
David T Miller, Margaret P Adam, Swaroop Aradhya, Leslie G Biesecker, Arthur R Brothman, Nigel P Carter, Deanna M Church, John A Crolla, Evan E Eichler, Charles J Epstein,[...]. Am J Hum Genet 2010
40


Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Siddharth Srivastava, Jamie A Love-Nichols, Kira A Dies, David H Ledbetter, Christa L Martin, Wendy K Chung, Helen V Firth, Thomas Frazier, Robin L Hansen, Lisa Prock,[...]. Genet Med 2019
98
26

The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource.
Clara D M van Karnebeek, Michael Shevell, Johannes Zschocke, John B Moeschler, Sylvia Stockler. Mol Genet Metab 2014
71
26



Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
Glen R Monroe, Gerardus W Frederix, Sanne M C Savelberg, Tamar I de Vries, Karen J Duran, Jasper J van der Smagt, Paulien A Terhal, Peter M van Hasselt, Hester Y Kroes, Nanda M Verhoeven-Duif,[...]. Genet Med 2016
98
20



Do the data really support ordering fragile X testing as a first-tier test without clinical features?
Veronique Weinstein, Pranoot Tanpaiboon, Kimberly A Chapman, Nicholas Ah Mew, Sean Hofherr. Genet Med 2017
11
18


Is it time to retire fragile X testing as a first-tier test for developmental delay, intellectual disability, and autism spectrum disorder?
Sureni V Mullegama, Steven D Klein, Dzung C Nguyen, Arang Kim, Rebecca Signer, Michelle Fox, Naghmeh Dorrani, Andrea Hendershot, Rebecca Mardach, Robert Suddath,[...]. Genet Med 2017
10
20

Molecular findings among patients referred for clinical whole-exome sequencing.
Yaping Yang, Donna M Muzny, Fan Xia, Zhiyv Niu, Richard Person, Yan Ding, Patricia Ward, Alicia Braxton, Min Wang, Christian Buhay,[...]. JAMA 2014
792
13

Fragile X testing as a second-tier test.
Taila Hartley, Ryan Potter, Lauren Badalato, Amanda C Smith, Olga Jarinova, Kym M Boycott. Genet Med 2017
5
40

Benefits, shortcomings, and costs of EEG monitoring.
R M Green, W J Messick, J J Ricotta, M H Charlton, R Satran, M M McBride, J A DeWeese. Ann Surg 1985
97
13

The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results.
Dustin Baldridge, Jennifer Heeley, Marisa Vineyard, Linda Manwaring, Tomi L Toler, Emily Fassi, Elise Fiala, Sarah Brown, Charles W Goss, Marcia Willing,[...]. Genet Med 2017
47
13


Genetic Testing among Children in a Complex Care Program.
Krista Oei, Robin Z Hayeems, Wendy J Ungar, Ronald D Cohn, Eyal Cohen. Children (Basel) 2017
7
28

Reducing the Cost of the Diagnostic Odyssey in Early Onset Epileptic Encephalopathies.
Charuta Joshi, Diana L Kolbe, M Adela Mansilla, Sara O Mason, Richard J H Smith, Colleen A Campbell. Biomed Res Int 2016
32
13

Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.
Robin Z Hayeems, Jasmin Bhawra, Kate Tsiplova, M Stephen Meyn, Nasim Monfared, Sarah Bowdin, D James Stavropoulos, Christian R Marshall, Raveen Basran, Cheryl Shuman,[...]. Eur J Hum Genet 2017
15
13

Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases.
Deborah Schofield, Khurshid Alam, Lyndal Douglas, Rupendra Shrestha, Daniel G MacArthur, Mark Davis, Nigel G Laing, Nigel F Clarke, Joshua Burns, Sandra T Cooper,[...]. NPJ Genom Med 2017
40
13

Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data.
Caroline F Wright, Tomas W Fitzgerald, Wendy D Jones, Stephen Clayton, Jeremy F McRae, Margriet van Kogelenberg, Daniel A King, Kirsty Ambridge, Daniel M Barrett, Tanya Bayzetinova,[...]. Lancet 2015
363
13

Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine.
Dimitri J Stavropoulos, Daniele Merico, Rebekah Jobling, Sarah Bowdin, Nasim Monfared, Bhooma Thiruvahindrapuram, Thomas Nalpathamkalam, Giovanna Pellecchia, Ryan K C Yuen, Michael J Szego,[...]. NPJ Genom Med 2016
165
13

Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
Tracy Yuen, Melissa T Carter, Peter Szatmari, Wendy J Ungar. Appl Health Econ Health Policy 2018
6
33

Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
Tiong Yang Tan, Oliver James Dillon, Zornitza Stark, Deborah Schofield, Khurshid Alam, Rupendra Shrestha, Belinda Chong, Dean Phelan, Gemma R Brett, Emma Creed,[...]. JAMA Pediatr 2017
136
13


A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
Lisenka E L M Vissers, Kirsten J M van Nimwegen, Jolanda H Schieving, Erik-Jan Kamsteeg, Tjitske Kleefstra, Helger G Yntema, Rolph Pfundt, Gert Jan van der Wilt, Lotte Krabbenborg, Han G Brunner,[...]. Genet Med 2017
100
13

Interrogating the "unsequenceable" genomic trinucleotide repeat disorders by long-read sequencing.
Qian Liu, Peng Zhang, Depeng Wang, Weihong Gu, Kai Wang. Genome Med 2017
35
13


Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
Anath C Lionel, Gregory Costain, Nasim Monfared, Susan Walker, Miriam S Reuter, S Mohsen Hosseini, Bhooma Thiruvahindrapuram, Daniele Merico, Rebekah Jobling, Thomas Nalpathamkalam,[...]. Genet Med 2018
176
13

Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
Michelle M Clark, Zornitza Stark, Lauge Farnaes, Tiong Y Tan, Susan M White, David Dimmock, Stephen F Kingsmore. NPJ Genom Med 2018
150
13

The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.
Nick Dragojlovic, Alison M Elliott, Shelin Adam, Clara van Karnebeek, Anna Lehman, Jill C Mwenifumbo, Tanya N Nelson, Christèle du Souich, Jan M Friedman, Larry D Lynd. Genet Med 2018
38
13

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
Zornitza Stark, Deborah Schofield, Khurshid Alam, William Wilson, Nessie Mupfeki, Ivan Macciocca, Rupendra Shrestha, Susan M White, Clara Gaff. Genet Med 2017
108
13


Prevalence of intellectual disability: a meta-analysis of population-based studies.
Pallab K Maulik, Maya N Mascarenhas, Colin D Mathers, Tarun Dua, Shekhar Saxena. Res Dev Disabil 2011
560
13

Genetic studies in intellectual disability and related disorders.
Lisenka E L M Vissers, Christian Gilissen, Joris A Veltman. Nat Rev Genet 2016
311
13

PRPS1 mutations: four distinct syndromes and potential treatment.
Arjan P M de Brouwer, Hans van Bokhoven, Sander B Nabuurs, Willem Frans Arts, John Christodoulou, John Duley. Am J Hum Genet 2010
62
13

Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Agatino Battaglia, Viola Doccini, Laura Bernardini, Antonio Novelli, Sara Loddo, Anna Capalbo, Tiziana Filippi, John C Carey. Eur J Paediatr Neurol 2013
118
13

Diagnostic Yield of Intellectual Disability Gene Panels.
Heather Pekeles, Andrea Accogli, Nassima Boudrahem-Addour, Laura Russell, Fabienne Parente, Myriam Srour. Pediatr Neurol 2019
8
25



Intellectual Disabilities.
Oscar Purugganan. Pediatr Rev 2018
10
20

Autism spectrum disorder: advances in evidence-based practice.
Evdokia Anagnostou, Lonnie Zwaigenbaum, Peter Szatmari, Eric Fombonne, Bridget A Fernandez, Marc Woodbury-Smith, Jessica Brian, Susan Bryson, Isabel M Smith, Irene Drmic,[...]. CMAJ 2014
75
6

Practice patterns and determinants of wait time for autism spectrum disorder diagnosis in Canada.
Melanie Penner, Evdokia Anagnostou, Wendy J Ungar. Mol Autism 2018
9
11

Diagnostic procedures in autism spectrum disorders: a systematic literature review.
Torbjörn Falkmer, Katie Anderson, Marita Falkmer, Chiara Horlin. Eur Child Adolesc Psychiatry 2013
143
6


Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study.
Sally Ozonoff, Gregory S Young, Alice Carter, Daniel Messinger, Nurit Yirmiya, Lonnie Zwaigenbaum, Susan Bryson, Leslie J Carver, John N Constantino, Karen Dobkins,[...]. Pediatrics 2011
666
6

Access Barriers to Services by Immigrant Mothers of Children with Autism in Canada.
Nazilla Khanlou, Nasim Haque, Nida Mustafa, Luz Maria Vazquez, Anne Mantini, Jonathan Weiss. Int J Ment Health Addict 2017
15
6

Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.
Jon Baio, Lisa Wiggins, Deborah L Christensen, Matthew J Maenner, Julie Daniels, Zachary Warren, Margaret Kurzius-Spencer, Walter Zahorodny, Cordelia Robinson Rosenberg, Tiffany White,[...]. MMWR Surveill Summ 2018
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.